USD 0.01
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Operating Expenses | 3.23 Million | 1.07 Million | 12.89 Million | 1.92 Million | 615.09 Thousand |
Selling, General and Administrative Expenses | 3.23 Million | 643.04 Thousand | 1.46 Million | 557.36 Thousand | 340.77 Thousand |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | - | - | -6.87 Million | 5000.00 | 90 Thousand |
Cost and Expenses | 3.23 Million | 1.07 Million | 12.89 Million | 1.92 Million | 615.09 Thousand |
Operating Income | -3.23 Million | -1.06 Million | -19.79 Million | -1.88 Million | -615.09 Thousand |
Interest Expense | - | 964.00 | 3101.00 | 4576.00 | - |
Income Tax Expense | - | -17.9 Thousand | -6.93 Million | -46.03 Thousand | -567.67 Thousand |
Earnings before Tax | -3.19 Million | -4.04 Million | -19.79 Million | -1.89 Million | -470.29 Thousand |
Net Income | -3.19 Million | -4.04 Million | -19.79 Million | -1.89 Million | -470.29 Thousand |
Earnings Per Share Basic | -0.01 | -0.01 | -0.13 | -0.03 | -0.02 |
Earnings Per Share Diluted | -0.01 | -0.01 | -0.13 | -0.03 | -0.02 |
Weighted Average Shares Outstanding | 494.73 Million | 280.6 Million | 148.33 Million | 58.41 Million | 25.79 Million |
Weighted Average Shares Outstanding (Diluted) | 494.71 Million | 280.59 Million | 148.33 Million | 58.41 Million | 25.79 Million |
Gross Margin | - | - | - | - | - |
EBIT Margin | - | - | - | - | - |
Profit Margin | - | - | - | - | - |
EBITDA | -3.23 Million | -1.04 Million | -801.12 Thousand | -1.86 Million | - |
Earnings Before Tax Margin | - | - | - | - | - |
Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 944.10 | 944.10 | 672.41 | 672.41 | 1.07 Million | 1746.54 |
Selling, General and Administrative Expenses | 944.10 | 944.10 | 672.41 | 672.41 | - | 249.67 |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 944.10 | 944.10 | 672.41 | 672.41 | 1.07 Million | 1746.54 |
Operating Income | -944.10 | -944.10 | -672.41 | -672.41 | -1.06 Million | -258.27 |
Interest Expense | - | - | - | - | 964.00 | - |
Income Tax Expense | -6.75 | -6.75 | 11.84 | 11.84 | -17.9 Thousand | - |
Earnings before Tax | -934.95 | -934.95 | -660.57 | -660.57 | -4.04 Million | -1733.73 |
Net Income | -934.95 | -934.95 | -660.57 | -660.57 | -4.04 Million | -1733.73 |
Earnings Per Share Basic | - | -0.00 | -0.00 | -0.00 | - | -0.01 |
Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.00 | - | -0.01 |
Weighted Average Shares Outstanding | 533.94 Million | 533.94 Million | 455.56 Million | 455.56 Million | 280.6 Million | 348.2 Million |
Weighted Average Shares Outstanding (Diluted) | 533.86 Million | 533.86 Million | 455.56 Million | 455.56 Million | 280.59 Million | 348.16 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -944.10 | -944.10 | 11.84 | 11.84 | - | -249.67 |
Earnings Before Tax Margin | - | - | - | - | - | - |
BROOKS
GB00BL9YR756
3249
BOD
RESONANCE
ISOP